MetaCap

Genenta Science S.p.A. ADR Company Profile

NASDAQ: SAENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.5074-0.0526 (-9.39%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Genenta Science S.p.A. at a glance

Genenta Science S.p.A. ADR (NASDAQ: SAEN) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Milan, MI, Italy. Genenta Science S.p.A. is led by Mr. Pierluigi Paracchi and employs about 9 people. The company's shares have traded publicly since 2021.

At a market capitalization of $24.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001838716, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Genenta Science S.p.A. do?

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Business description based on the company's public filings.

Company information

Legal name
Genenta Science S.p.A. ADR
Ticker
NASDAQ: SAEN
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Mr. Pierluigi Paracchi
Employees
9
Headquarters
Via dell’Annunciata 31, Milan, MI, Italy
Phone
39 02 29 00 10 55
IPO year
2021
Market cap
$24.47M
SEC CIK
0001838716

Companies similar to Genenta Science S.p.A.

SAEN peer companies
CompanyPrice% ChgMarket capCompare
PTHSPelthos Therapeutics Inc.6.38-8.73%$25.08Mvs SAEN
INMBINmune Bio Inc.0.827-7.50%$25.60Mvs SAEN
LONALeonaBio Inc.2.02-17.89%$26.41Mvs SAEN
EXOZeXoZymes Inc.2.91-14.05%$27.42Mvs SAEN
MGXMetagenomi Therapeutics Inc.0.565-7.95%$21.36Mvs SAEN
CVMCel-Sci Corporation1.21-17.69%$21.28Mvs SAEN
EVAXEvaxion A/S ADR2.25+10.84%$20.75Mvs SAEN
KLRSKalaris Therapeutics Inc.1.28-5.19%$30.47Mvs SAEN

Related